{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:01:39Z","timestamp":1784707299607,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10787-026-02286-3","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:37:16Z","timestamp":1781246236000},"page":"4831-4850","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ruxolitinib phosphate-laden nanoemulgel: amelioration of ex vivo permeation and in vivo therapeutic efficacy for the effective therapeutic management of psoriasis"],"prefix":"10.1007","volume":"34","author":[{"given":"Ratnam","family":"Sreya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Nene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vrushali","family":"Pathade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Vambhurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Phatale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"2286_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.33545\/26649411.2019.v2.i1a.112","volume":"2","author":"MK Agarwala","year":"2019","unstructured":"Agarwala MK, Chandrakar R, Arora R (2019) A hospital based assessment of the effects of various topical agents in chronic plaque type psoriasis. Int J Dermatol Venereol Lepr Sci 2:22\u201324. https:\/\/doi.org\/10.33545\/26649411.2019.v2.i1a.112","journal-title":"Int J Dermatol Venereol Lepr Sci"},{"key":"2286_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4103\/2230-973x.133053","volume":"4","author":"G Aggarwal","year":"2014","unstructured":"Aggarwal G, Dhawan B, Harikumar S (2014) Enhanced transdermal permeability of piroxicam through novel nanoemulgel formulation. Int J Pharm Investig 4:65. https:\/\/doi.org\/10.4103\/2230-973x.133053","journal-title":"Int J Pharm Investig"},{"issue":"5","key":"2286_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/PH18050633","volume":"18","author":"R Albash","year":"2025","unstructured":"Albash R, Ali SK, Abdelmonem R et al (2025a) Electrospun nanofiber-scaffold-loaded Levocetirizine Dihydrochloride cerosomes for combined management of atopic dermatitis and Methicillin-Resistant Staphylococcus aureus (MRSA) skin infection: in vitro and in vivo studies. Pharmaceuticals Basel 18(5):633. https:\/\/doi.org\/10.3390\/PH18050633","journal-title":"Pharmaceuticals Basel"},{"key":"2286_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2025.1595177\/ABSTRACT","author":"R Albash","year":"2025","unstructured":"Albash R, Azzazy HME, Mosallam S et al (2025b) Stearyl amine-modified elastic cerosomes for boosting the anti-cancer activity of albendazole. Front Pharmacol. https:\/\/doi.org\/10.3389\/FPHAR.2025.1595177\/ABSTRACT","journal-title":"Front Pharmacol"},{"issue":"3","key":"2286_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS18030364","volume":"18","author":"R Albash","year":"2026","unstructured":"Albash R, Fahmy AM, Ragaie MH et al (2026) Innovative nanocarriers: elastic aspasomes loaded with Metformin Hydrochloride for effective management of melasma: in vitro studies and clinical appraisal. Pharmaceutics 18(3):364. https:\/\/doi.org\/10.3390\/PHARMACEUTICS18030364","journal-title":"Pharmaceutics"},{"key":"2286_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS17121616","volume":"17","author":"R Albash","year":"2025","unstructured":"Albash R, Hassan M, Agiba AM et al (2025c) PEGylated terpesome-loaded 3D-printed Aripiprazole ocuserts for the treatment of ocular candidiasis. Pharmaceutics 17:1616. https:\/\/doi.org\/10.3390\/PHARMACEUTICS17121616","journal-title":"Pharmaceutics"},{"key":"2286_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/NANO10050848","volume":"10","author":"MS Algahtani","year":"2020","unstructured":"Algahtani MS, Ahmad MZ, Ahmad J (2020) Nanoemulgel for improved topical delivery of Retinyl palmitate: formulation design and stability evaluation. Nanomaterials 2020 10:848. https:\/\/doi.org\/10.3390\/NANO10050848","journal-title":"Nanomaterials 2020"},{"key":"2286_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.104145","author":"S Atmakuri","year":"2023","unstructured":"Atmakuri S, Nene S, Jain H et al (2023) Topical delivery of tofacitinib citrate loaded novel nanoemulgel for the management of 2,4-Dichlorodinitrobenzene induced atopic dermatitis in mice model. J Drug Deliv Sci Technol. https:\/\/doi.org\/10.1016\/j.jddst.2022.104145","journal-title":"J Drug Deliv Sci Technol"},{"key":"2286_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1208\/s12249-008-9178-x","volume":"10","author":"A Azeem","year":"2009","unstructured":"Azeem A, Rizwan M, Ahmad FJ et al (2009) Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech 10:69\u201376. https:\/\/doi.org\/10.1208\/s12249-008-9178-x","journal-title":"AAPS PharmSciTech"},{"key":"2286_CR10","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.colsurfb.2009.11.021","volume":"76","author":"V Bali","year":"2010","unstructured":"Bali V, Ali M, Ali J (2010) Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids Surf B Biointerfaces 76:410\u2013420. https:\/\/doi.org\/10.1016\/j.colsurfb.2009.11.021","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2286_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25153321","author":"A Coricello","year":"2020","unstructured":"Coricello A, Mesiti F, Lupia A et al (2020) Inside perspective of the synthetic and computational toolbox of JAK inhibitors: recent updates. Molecules. https:\/\/doi.org\/10.3390\/molecules25153321","journal-title":"Molecules"},{"key":"2286_CR12","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/s41590-018-0256-2","volume":"19","author":"T Dainichi","year":"2018","unstructured":"Dainichi T, Kitoh A, Otsuka A et al (2018) The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis. Nat Immunol 19:1286\u20131298. https:\/\/doi.org\/10.1038\/s41590-018-0256-2","journal-title":"Nat Immunol"},{"key":"2286_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/PHARMACEUTICS15010164","volume":"15","author":"MR Donthi","year":"2023","unstructured":"Donthi MR, Munnangi SR, Krishna KV et al (2023) Nanoemulgel: a novel nano carrier as a tool for topical drug delivery. Pharmaceutics 15:164. https:\/\/doi.org\/10.3390\/PHARMACEUTICS15010164","journal-title":"Pharmaceutics"},{"key":"2286_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/980419","author":"S Dubois Declercq","year":"2013","unstructured":"Dubois Declercq S, Pouliot R (2013) Promising new treatments for psoriasis. Sci World J. https:\/\/doi.org\/10.1155\/2013\/980419","journal-title":"Sci World J"},{"key":"2286_CR15","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1002\/eji.201343801","volume":"43","author":"B Flutter","year":"2013","unstructured":"Flutter B, Nestle FO (2013) TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis. Eur J Immunol 43:3138\u20133146. https:\/\/doi.org\/10.1002\/eji.201343801","journal-title":"Eur J Immunol"},{"key":"2286_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108622","author":"JP Gokhale","year":"2019","unstructured":"Gokhale JP, Mahajan HS, Surana SS (2019) Quercetin loaded nanoemulsion-based gel for rheumatoid arthritis: in vivo and in vitro studies. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2019.108622","journal-title":"Biomed Pharmacother"},{"key":"2286_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122535","author":"GS Gomes","year":"2023","unstructured":"Gomes GS, Frank LA, Contri RV et al (2023) Nanotechnology-based alternatives for the topical delivery of immunosuppressive agents in psoriasis. Int J Pharm. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122535","journal-title":"Int J Pharm"},{"key":"2286_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s40257-023-00840-1","volume":"25","author":"W Hu","year":"2024","unstructured":"Hu W, Thornton M, Livingston RA (2024) Real-world use of Ruxolitinib cream: safety analysis at 1 year. Am J Clin Dermatol 25:327\u2013332. https:\/\/doi.org\/10.1007\/s40257-023-00840-1","journal-title":"Am J Clin Dermatol"},{"key":"2286_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103103","author":"H Jain","year":"2022","unstructured":"Jain H, Geetanjali D, Dalvi H et al (2022a) Liposome mediated topical delivery of Ibrutinib and Curcumin as a synergistic approach to combat imiquimod induced psoriasis. J Drug Deliv Sci Technol. https:\/\/doi.org\/10.1016\/j.jddst.2022.103103","journal-title":"J Drug Deliv Sci Technol"},{"key":"2286_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/J.JDDST.2022.103103","volume":"68","author":"H Jain","year":"2022","unstructured":"Jain H, Geetanjali D, Dalvi H et al (2022b) Liposome mediated topical delivery of Ibrutinib and Curcumin as a synergistic approach to combat Imiquimod induced psoriasis. J Drug Deliv Sci Technol 68:103103. https:\/\/doi.org\/10.1016\/J.JDDST.2022.103103","journal-title":"J Drug Deliv Sci Technol"},{"key":"2286_CR21","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.nano.2017.02.009","volume":"13","author":"A Kaur","year":"2017","unstructured":"Kaur A, Katiyar SS, Kushwah V, Jain S (2017) Nanoemulsion loaded gel for topical co-delivery of Clobetasol propionate and Calcipotriol in psoriasis. Nanomedicine 13:1473\u20131482. https:\/\/doi.org\/10.1016\/j.nano.2017.02.009","journal-title":"Nanomedicine"},{"key":"2286_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/gels9020112","author":"R Khan","year":"2023","unstructured":"Khan R, Mirza MA, Aqil M et al (2023) In vitro and in vivo investigation of a dual-targeted nanoemulsion gel for the amelioration of psoriasis. Gels. https:\/\/doi.org\/10.3390\/gels9020112","journal-title":"Gels"},{"key":"2286_CR23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41584-019-0337-0","volume":"16","author":"KM Kingsmore","year":"2020","unstructured":"Kingsmore KM, Grammer AC, Lipsky PE (2020) Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases. Nat Rev Rheumatol 16:32\u201352. https:\/\/doi.org\/10.1038\/s41584-019-0337-0","journal-title":"Nat Rev Rheumatol"},{"key":"2286_CR24","doi-asserted-by":"publisher","DOI":"10.1039\/d2na00530a","author":"L Liu","year":"2023","unstructured":"Liu L, Zhao W, Ma Q et al (2023) Functional nano-systems for transdermal drug delivery and skin therapy. Nanoscale Adv. https:\/\/doi.org\/10.1039\/d2na00530a","journal-title":"Nanoscale Adv"},{"key":"2286_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4071818","author":"S Md","year":"2020","unstructured":"Md S, Alhakamy NA, Aldawsari HM et al (2020) Improved analgesic and anti-inflammatory effect of Diclofenac sodium by topical nanoemulgel: formulation development\u2014in vitro and in vivo studies. J Chem. https:\/\/doi.org\/10.1155\/2020\/4071818","journal-title":"J Chem"},{"key":"2286_CR26","first-page":"394","volume":"13","author":"RAM Mesa","year":"2010","unstructured":"Mesa RAM (2010) Ruxolitinib, a selective JAK1 and JAK2 inhibitor for the treatment of myeloproliferative neoplasms and psoriasis. Idrugs 13:394\u2013403","journal-title":"Idrugs"},{"key":"2286_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2026.214835","volume":"184","author":"M Negi","year":"2026","unstructured":"Negi M, Amulya E, Phatale V et al (2026) Nose-to-brain delivery of berberine-loaded nanoemulsion: amelioration of brain targeting, behavioral, pharmacokinetic, and biodistribution insights for Alzheimer\u2019s intervention. Biomater Adv 184:214835. https:\/\/doi.org\/10.1016\/j.bioadv.2026.214835","journal-title":"Biomater Adv"},{"key":"2286_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-024-01565-2","author":"S Nene","year":"2024","unstructured":"Nene S, Devabattula G, Vambhurkar G et al (2024) High mobility group box 1 cytokine targeted topical delivery of resveratrol embedded nanoemulgel for the management of atopic dermatitis. Drug Deliv Transl Res. https:\/\/doi.org\/10.1007\/s13346-024-01565-2","journal-title":"Drug Deliv Transl Res"},{"key":"2286_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4103\/0975-7406.168037","volume":"7","author":"R Parveen","year":"2015","unstructured":"Parveen R, Baboota S, Ali J et al (2015) Stability studies of silymarin nanoemulsion containing Tween 80 as a surfactant. J Pharm Bioallied Sci 7:321\u2013324. https:\/\/doi.org\/10.4103\/0975-7406.168037","journal-title":"J Pharm Bioallied Sci"},{"key":"2286_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0378-5173(01)00759-1","volume":"226","author":"E Peira","year":"2001","unstructured":"Peira E, Scolari P, Gasco MR (2001) Transdermal permeation of apomorphine through hairless mouse skin from microemulsions. Int J Pharm 226:47\u201351. https:\/\/doi.org\/10.1016\/S0378-5173(01)00759-1","journal-title":"Int J Pharm"},{"key":"2286_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJBIOMAC.2025.143089","volume":"310","author":"A Priyadarshinee","year":"2025","unstructured":"Priyadarshinee A, Amulya E, Vambhurkar G et al (2025) Unveiling the revolutionary approach for psoriasis management: leveraging the breakthrough capabilities of hyaluronic acid. Int J Biol Macromol 310:143089. https:\/\/doi.org\/10.1016\/J.IJBIOMAC.2025.143089","journal-title":"Int J Biol Macromol"},{"key":"2286_CR32","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jaad.2011.12.018","volume":"67","author":"N Punwani","year":"2012","unstructured":"Punwani N, Scherle P, Flores R et al (2012) Preliminary clinical activity of a topical JAK1\/2 inhibitor in the treatment of psoriasis. J Am Acad Dermatol 67:658\u2013664. https:\/\/doi.org\/10.1016\/j.jaad.2011.12.018","journal-title":"J Am Acad Dermatol"},{"key":"2286_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S44174-025-00541-9","volume":"2025","author":"M Rahaman","year":"2025","unstructured":"Rahaman M, Basu B, Ghosh S et al (2025) Nanoemulsion-based therapies: a promising approach for managing psoriasis. Biomed Mater Devices 2025:1\u201319. https:\/\/doi.org\/10.1007\/S44174-025-00541-9","journal-title":"Biomed Mater Devices"},{"key":"2286_CR34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2174\/187153012802002901","volume":"12","author":"M Rahman","year":"2012","unstructured":"Rahman M, Alam K, Ahmad MZ et al (2012) Classical to current approach for treatment of psoriasis: a review. Endocr Metab Immune Disord Drug Targets 12:287\u2013302. https:\/\/doi.org\/10.2174\/187153012802002901","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"2286_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113127","author":"VK Rai","year":"2020","unstructured":"Rai VK, Sinha P, Yadav KS et al (2020) Anti-psoriatic effect of Lavandula angustifolia essential oil and its major components linalool and linalyl acetate. J Ethnopharmacol. https:\/\/doi.org\/10.1016\/j.jep.2020.113127","journal-title":"J Ethnopharmacol"},{"key":"2286_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101691","author":"R Saka","year":"2020","unstructured":"Saka R, Jain H, Kommineni N et al (2020a) Enhanced penetration and improved therapeutic efficacy of bexarotene via topical liposomal gel in imiquimod induced psoriatic plaque model in BALB\/c mice. J Drug Deliv Sci Technol. https:\/\/doi.org\/10.1016\/j.jddst.2020.101691","journal-title":"J Drug Deliv Sci Technol"},{"key":"2286_CR37","unstructured":"Salim N, Ahmad N, Musa S, et al Nanoemulsion as a topical delivery system of antipsoriatic drugs. pubs.rsc.org"},{"key":"2286_CR38","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ejpb.2006.10.014","volume":"66","author":"S Shafiq","year":"2007","unstructured":"Shafiq S, Shakeel F, Talegaonkar S et al (2007) Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm 66:227\u2013243. https:\/\/doi.org\/10.1016\/j.ejpb.2006.10.014","journal-title":"Eur J Pharm Biopharm"},{"key":"2286_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18900-7","author":"H Shinno-Hashimoto","year":"2022","unstructured":"Shinno-Hashimoto H, Eguchi A, Sakamoto A et al (2022) Effects of splenectomy on skin inflammation and psoriasis-like phenotype of imiquimod-treated mice. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-022-18900-7","journal-title":"Sci Rep"},{"key":"2286_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112322","author":"A Siddiqui","year":"2022","unstructured":"Siddiqui A, Jain P, Alex TS et al (2022) Investigation of a minocycline-loaded nanoemulgel for the treatment of acne rosacea. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14112322","journal-title":"Pharmaceutics"},{"key":"2286_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121909","author":"VK Singh","year":"2023","unstructured":"Singh VK, Sahoo D, Agrahari K et al (2023) Anti-inflammatory, anti-proliferative and anti-psoriatic potential of apigenin in RAW 264.7 cells, HaCaT cells and psoriasis like dermatitis in BALB\/c mice. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2023.121909","journal-title":"Life Sci"},{"key":"2286_CR42","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jconrel.2017.03.008","volume":"252","author":"Y Singh","year":"2017","unstructured":"Singh Y, Meher JG, Raval K et al (2017) Nanoemulsion: concepts, development and applications in drug delivery. J Control Release 252:28\u201349. https:\/\/doi.org\/10.1016\/j.jconrel.2017.03.008","journal-title":"J Control Release"},{"key":"2286_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10194307","author":"S S\u0142uczanowska-G\u0142abowska","year":"2021","unstructured":"S\u0142uczanowska-G\u0142abowska S, Ziegler-Krawczyk A, Szumilas K, Pawlik A (2021a) Role of janus kinase inhibitors in therapy of psoriasis. J Clin Med. https:\/\/doi.org\/10.3390\/jcm10194307","journal-title":"J Clin Med"},{"key":"2286_CR44","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s10787-023-01257-2","volume":"31","author":"R Sreya","year":"2023","unstructured":"Sreya R, Nene S, Pathade V et al (2023) Emerging trends in combination strategies with phototherapy in advanced psoriasis management. Inflammopharmacology 31:1761\u20131778. https:\/\/doi.org\/10.1007\/s10787-023-01257-2","journal-title":"Inflammopharmacology"},{"key":"2286_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/1346-8138.12367","volume":"41","author":"A Ueyama","year":"2014","unstructured":"Ueyama A, Yamamoto M, Tsujii K et al (2014) Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod. J Dermatol 41:135\u2013143. https:\/\/doi.org\/10.1111\/1346-8138.12367","journal-title":"J Dermatol"},{"key":"2286_CR46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.5530\/ijpi.2022.2.35","volume":"12","author":"V Verma","year":"2022","unstructured":"Verma V, Easwari TS (2022) A novel approach of leflunomide nanoemulgel for topical drug delivery system. Int J Pharm Investig 12:199\u2013204. https:\/\/doi.org\/10.5530\/ijpi.2022.2.35","journal-title":"Int J Pharm Investig"},{"key":"2286_CR47","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3109\/10717544.2015.1110845","volume":"23","author":"S Wadhwa","year":"2016","unstructured":"Wadhwa S, Singh B, Sharma G et al (2016) Liposomal fusidic acid as a potential delivery system: a new paradigm in the treatment of chronic plaque psoriasis. Drug Deliv 23:1204\u20131213. https:\/\/doi.org\/10.3109\/10717544.2015.1110845","journal-title":"Drug Deliv"},{"key":"2286_CR48","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.toxrep.2017.06.003","volume":"4","author":"J Wang","year":"2017","unstructured":"Wang J, Li Z, Sun F et al (2017) Evaluation of dermal irritation and skin sensitization due to vitacoxib. Toxicol Rep 4:287\u2013290. https:\/\/doi.org\/10.1016\/j.toxrep.2017.06.003","journal-title":"Toxicol Rep"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02286-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02286-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02286-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:16:01Z","timestamp":1784704561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02286-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2286"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02286-3","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"1 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Male BALB\/c mice with a weight range of 20\u201330\u00a0g were purchased from the Vyas Labs, Hyderabad. The experimental animal protocol was approved by the institutional animal ethics committee (IAEC) (NIP\/01\/2022\/PE\/515). The investigative techniques were carried out according to the CPCSEA, India, requirements. Animals were maintained in the central animal house facility (NIPER, Hyderabad) under regulated lighting and temperature conditions and fed on a standard dry diet and water. Animals were acclimated for a week before the start of the study.","order":4,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}